Pluribus Labs’s REV Group REVG Stock Holding History

Pluribus Labs’s Portfolio REVG Stock Details REVG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,767	Closed	-$266K	–	187
2021 Q4	$266K	Buy	+18,767	New	+$297K	0.28%	154

Other funds holding REVG

AIP LLC New York $268M AUM 40.4% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pluribus Labs's REVG Position: Q1 2022 in Review

Pluribus Labs sold out of REV Group (REVG) in Q1 2022, closing a stake of 18,767 shares — an estimated $266K sold.

Pluribus Labs first reported a position in REVG in Q4 2021 and held it in 1 quarter. The position peaked at $266K in Q4 2021. 114 funds tracked by Wall St. Rank hold REVG as of Q1 2022.

Pluribus Labs reported no remaining REV Group position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 18,767 REV Group shares in Q1 2022, an estimated $266K.
Pluribus Labs first reported a position in REV Group in Q4 2021 and held it in 1 quarter.
Pluribus Labs's REV Group position peaked at $266K in Q4 2021.
114 funds tracked by Wall St. Rank held REV Group as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.